Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
9
×
life sciences
national blog main
biotech
fda
boston blog main
national top stories
amgen
boston top stories
new york blog main
eli lilly
new york top stories
deals
new york
san francisco blog main
alnylam pharmaceuticals
boston
calcitonin gene-related peptide
cholesterol
chronic migraine
detroit blog main
detroit top stories
drugs
episodic migraine
inclisiran
indiana blog main
indiana top stories
investing
migraine
national
novartis
pcsk9 inhibitors
regeneron pharmaceuticals
san diego blog main
san diego top stories
san francisco top stories
teva pharmaceutical
abbvie
akcea therapeutics
akouos
What
fda
9
×
medicines
9
×
drug
approved
new
approval
cholesterol
class
migraine
nod
wins
developed
lowering
medco
pain
pill
regulatory
starts
therapeutics
treat
won
acquire
adults
affects
ago
agreed
akcea
allergan
alnylam
americans
amgen
amyloidosis
announced
attr
available
battle
billion
blueprint
bringing
brings
Language
unset
Current search:
medicines
×
fda
×
" clinical trials "
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines